解开PD-1/PD-L1轴的奥秘:超越检查点的作
Pierre-Hubert Desimpel1,2, Pierre-Florent Petit3, Benoit J Van den Eynde1,2,4,5
1Immunity & Cancer Research Program, De Duve Institute, Brussels, Belgium.
Frontiers in immunology
|December 22, 2025
概括
编程细胞死亡蛋白1 (PD-1) 和其连接体PD-L1通路比以前认为的更复杂. 新的研究揭示了多样化的细胞表达和功能,影响癌症免疫力和治疗.
科学领域:
- 免疫学 免疫学 免疫学
- 癌症生物学 癌症生物学
- 分子医学是分子医学.
背景情况:
- PD-1/PD-L1轴对免疫调节和癌症免疫治疗至关重要.
- 最初的模型提出了PD-L1对影响T细胞的瘤细胞的简单抑制作用.
- 最近的证据表明,监管网络更为复杂.
研究的目的:
- 探索PD-L1表达和功能的复杂调节机制.
- 研究PD-L1在瘤细胞之外的多种细胞来源和作用.
- 了解PD-L1在瘤细胞内的非免疫功能.
主要方法:
- 关于PD-1/PD-L1通路的最新科学文献的审查.
- 对研究不同细胞类型中PD-L1表达的研究进行分析.
- 对PD-L1内在细胞功能的研究进行了审查.
主要成果:
- PD-L1由多种细胞类型 (免疫,肌层,瘤) 表达,具有复杂的调节.
- PD-L1在瘤细胞中表现出非免疫功能,影响增殖和新陈代谢.
- PD-1在T细胞以外的其他细胞类型中得到表达,扩大了其监管范围.
结论:
- PD-1/PD-L1轴非常复杂,涉及细胞异质性和双向信号传输.
- 需要更精细的理解来改善癌症患者分层和治疗策略.
- 进一步的研究对于优化免疫检查点封锁组合至关重要.
相关概念视频
Interactions Between Signaling Pathways
7.1K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.1K
The Intrinsic Apoptotic Pathway
8.2K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
8.2K
The JAK-STAT Signaling Pathway
11.8K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
11.8K
Negative Regulator Molecules
38.2K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
38.2K
Abnormal Proliferation
5.1K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.1K
PI3K/mTOR/AKT Signaling Pathway
5.3K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
5.3K


